한글목차

세계 핸드헬드 수술기기 시장 규모는 예측기간에 CAGR로 5.42%의 성장이 예상되고 있습니다.

심혈관, 신경, 비뇨기 등의 만성 질환이나 난치성 질환의 발병 증가와, 저침습 수술에 있어서의 핸드헬드 수술 기기의 이용의 확대가, 시장의 성장 촉진요인이 되고 있습니다.

지역 고찰

북미 시장은 2022년에 가장 큰 시장 점유율을 차지했습니다. 북미 시장은 수익에서 가장 큰 시장입니다. 시장은 심혈관, 악성 종양, 신경, 면역 질환의 유행에 의해 견인되고 있습니다.

유럽은 두 번째로 큰 시장 점유율을 차지했습니다. 독일 시장이 가장 큰 시장 점유율을 차지하고 프랑스가 유럽에서 가장 빠르게 성장하고 있습니다.

아시아태평양 시장이 2023-2030년에 가장 급속히 성장할 전망입니다.

이 보고서는 세계 휴대용 수술 장비 시장에 대한 조사 분석, 시장 역학, 지역 및 부문 분석, 기업 프로파일 등을 제공합니다.

목차

제1장 주요 요약

• 개요
  • 시장 요약

제2장 시장의 소개

제3장 조사 방법

제4장 시장 역학

• 개요
• 성장 촉진요인
  • 심혈관 질환, 신경 질환, 비뇨기 질환, 감염증 등의 만성 질환의 유행
  • 저침습 수술에 있어서의 핸드헬드 수술 기기의 사용 증가
• 억제요인
  • 경쟁업체의 경쟁력 있는 가격 설정
• 기회
  • 미용 수술에 대한 수요 증가

제5장 시장 요인 분석

• 밸류체인 분석
  • 연구개발
  • 제조
  • 유통 및 판매
  • 판매 후 모니터링
• Porter's Five Forces 분석 모델
• 세계의 핸드헬드 수술 기기 시장에 대한 COVID-19의 영향
  • 공급망에 미치는 영향
  • 주요 기업에 미치는 영향
• 미국 주요 인원의 연락처 정보 목록
• 미국의 주요 제조업체와 그 제조 플랜트/공장의 총수

제6장 세계의 핸드헬드 수술기기 시장 : 제품 유형별

• 개요
• 글래스퍼
• 리트랙터
• 기계 커터
• 흡입 팁 및 튜브
• 관개 및 주사 바늘
• 스코프 및 프로브
• 봉합사
• 집게
• 족집게
• 기타

제7장 세계의 핸드헬드 수술기기 시장 : 용도별

• 개요
• 정형외과 수술
• 안과
• 심장
• 상처 케어
• 비뇨기과 및 부인과 수술
• 성형외과 수술
• 호흡기 수술 수술
• 뇌신경외과 수술
• 기타

제8장 세계의 핸드헬드 수술 기기 시장 : 최종 사용자별

• 개요
• 병원 및 진료소
• 외래수술센터(ASC)
• 기타

제9장 세계의 핸드헬드 수술기기 시장 : 지역별

• 소개
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스웨덴
  • 스페인
  • 기타 유럽
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타 아시아태평양
• 기타 지역
  • 중동
  • 아프리카
  • 라틴아메리카

제10장 경쟁 구도

• 개요
• 경쟁 벤치마킹
• 세계 핸드헬드 수술기기 시장의 주요 성장 전략
• 세계의 핸드헬드 수술기기 시장에 있어서의 개발수의 주요 기업
• 주요 개발 분석
• 주요 발전과 성장 전략
  • 제품/기업 출시/제품 승인
  • 합병/인수

제11장 기업 프로파일

• JOHNSON & JOHNSON SERVICES, INC.
• ZIMMER BIOMET HOLDINGS INC.
• B. BRAUN MELSUNGEN AG
• INTEGRA LIFESCIENCES HOLDINGS CORPORATION
• MEDTRONIC PLC
• BECTON, DICKINSON, AND COMPANY
• BOSTON SCIENTIFIC CORPORATION
• STRYKER
• SMITH AND NEPHEW
• MEDLINE INDUSTRIES, INC.
• ABBOTT
• PETERS SURGICAL
• COLOPLAST CORP.
• TERUMO MEDICAL CORPORATION
• OLYMPUS CORPORATION

제12장 부록

영문목차

Market Overview

Handheld Surgical Devices Market is anticipated to register a CAGR of 5.42% during the forecast period.

The developing instances of chronic diseases, for example, cardiovascular, neurological, urological, and irresistible sicknesses and expanding utilization of handheld devices in negligibly obtrusive medical procedures are central point driving the development of the Handheld Surgical Devices Market.

Ongoing illnesses, for example, cardiovascular, neurological, urological, and irresistible infections are expanding all around the world. Heart issues are turning out to be more normal than other constant illnesses because of an absence of active work, being overweight, smoking, unfortunate sustenance, or having a family ancestry. Moreover, diabetes, hypertension, and hyperlipidemia are all chance elements for cardiovascular illness. Individuals beyond 60 a year old at a higher gamble of creating illnesses, for example, cardiovascular, muscular, and neurological issues. Certain individuals with these circumstances or infections should go through a medical procedure. Consequently, an expansion in cardiovascular, muscular, and neurological issues is supposed to help the interest for handheld surgical devices. The utilization of great devices by specialists is a steady need to execute medical procedures effectively and rapidly without compromising the strength of the patient. Consequently, factors that are causing a flood in the requirement for handheld surgical devices incorporate the rising commonness of ongoing circumstances like cardiovascular, neurological, urological, and irresistible illnesses.

Segment Insights

The Handheld Surgical Devices Market segmentation, based on product type, includes graspers, retractors, mechanical cutters, suction tips and tubes, irrigation and injection needs, scopes and probes, sutures, forceps, tweezers, and others.

Based on application, the Handheld Surgical Devices Market includes orthopedic surgery, ophthalmology, cardiology, wound care, urology and gynecology surgery, plastic surgery, thoracic surgery, neurosurgery, and others. The end user segment includes hospitals & clinics, ambulatory surgical centers, and others.

Regional Insights

The North America handheld surgical devices market represented the biggest market share in 2022. The North America regional market is the biggest market with regards to income. The market is driven by the rising pervasiveness of cardiovascular, malignant growth, neurological, and immune system problems around here.

Europe handheld surgical ventures accounted for the second-biggest market share because of the developing interest for safe surgical devices that are utilized in negligibly obtrusive medical procedures, rising innovative work speculations, and expanding geriatric populace. Moreover, the Germany handheld surgical devices market credited to hold the biggest market share, and the France handheld surgical devices market is extended be the quickest developing market in the Europe area.

The Asia-Pacific handheld surgical devices market is supposed to be the quickest developing from 2023 to 2030 because of the developing populace, the rising spending force of purchasers, and the high commonness of persistent problems.

Major Players

Key Companies in the handheld surgical devices market includes Zimmer Biomet Holdings Inc. (US), Braun Melsungen AG (Germany). Becton, Dickinson and Company (US), Medline Industries Inc. (US), Peter Surgical (France), Medtronic Plc (Ireland), Abbott (US), Boston Scientific Corporation (US), Stryker (US), Smith & Nephew (UK), Coloplast Corp. (Denmark), Terumo Medical Corporation (Japan), Integra Lifesciences Holdings Corporation (US), Olympus Corporation (Japan), and Johnson & Johnson Services, Inc. (US).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW
  • 1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA MINING
• 3.3 SECONDARY RESEARCH
• 3.4 PRIMARY RESEARCH
  • 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 THE GROWING PREVALENCE OF CHRONIC DISORDERS, SUCH AS CARDIOVASCULAR, NEUROLOGICAL, UROLOGICAL, AND INFECTIOUS DISEASES
  • 4.2.2 INCREASING USE OF HANDHELD DEVICES IN MINIMALLY INVASIVE SURGERIES
• 4.3 RESTRAINTS
  • 4.3.1 COMPETITIVE PRICING AMONG COMPETITORS
• 4.4 OPPORTUNITIES
  • 4.4.1 GROWING DEMAND FOR AESTHETIC SURGERIES

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION & SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL HANDHELD SURGICAL DEVICES MARKET
  • 5.3.1 IMPACT ON SUPPLY CHAIN
  • 5.3.2 IMPACT ON KEY PLAYERS
• 5.4 LIST OF CONTACT INFORMATION FOR KEY PERSONNEL IN THE US
• 5.5 KEY MANUFACTURERS AND THEIR TOTAL NUMBER OF MANUFACTURING PLANTS/ FACTORIES IN THE US

6 GLOBAL HANDHELD SURGICAL DEVICES MARKET, BY PRODUCT TYPE

• 6.1 OVERVIEW
• 6.2 GRASPERS
• 6.3 RETRACTORS
• 6.4 MECHANICAL CUTTERS
• 6.5 SUCTION TIPS AND TUBES
• 6.6 IRRIGATION AND INJECTION NEEDS
• 6.7 SCOPES AND PROBES
• 6.8 SUTURES
• 6.9 FORCEPS
• 6.10 TWEEZERS
• 6.11 OTHERS

7 GLOBAL HANDHELD SURGICAL DEVICES MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 ORTHOPAEDIC SURGERY
• 7.3 OPHTHALMOLOGY
• 7.4 CARDIOLOGY
• 7.5 WOUND CARE
• 7.6 UROLOGY AND GYNAECOLOGY SURGERY
• 7.7 PLASTIC SURGERY
• 7.8 THORACIC SURGERY
• 7.9 NEUROSURGERY
• 7.10 OTHERS

8 GLOBAL HANDHELD SURGICAL DEVICES MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 HOSPITALS & CLINICS
• 8.3 AMBULATORY SURGICAL CENTERS
• 8.4 OTHERS

9 GLOBAL HANDHELD SURGICAL DEVICES MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 FRANCE
  • 9.3.3 UK
  • 9.3.4 ITALY
  • 9.3.5 SWEDEN
  • 9.3.6 SPAIN
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA-PACIFIC
  • 9.4.1 JAPAN
  • 9.4.2 CHINA
  • 9.4.3 INDIA
  • 9.4.4 AUSTRALIA
  • 9.4.5 SOUTH KOREA
  • 9.4.6 REST OF ASIA PACIFIC
• 9.5 REST OF THE WORLD
  • 9.5.1 MIDDLE EAST
  • 9.5.2 AFRICA
  • 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 COMPETITIVE BENCHMARKING
• 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL HANDHELD SURGICAL DEVICES MARKET
• 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL HANDHELD SURGICAL DEVICES MARKET
• 10.5 KEY DEVELOPMENT ANALYSIS
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 PRODUCT/COMPANY LAUNCH/PRODUCT APPROVAL
  • 10.6.2 MERGER/ACQUISITION

11 COMPANY PROFILES

• 11.1 JOHNSON & JOHNSON SERVICES, INC.
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 ZIMMER BIOMET HOLDINGS INC.
  • 11.2.1 COMPANY OVERVIEWS
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS/SERVICES OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 B. BRAUN MELSUNGEN AG
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 SWOT ANALYSIS
  • 11.3.6 KEY STRATEGIES
• 11.4 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 SWOT ANALYSIS
  • 11.4.6 KEY STRATEGIES
• 11.5 MEDTRONIC PLC
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 BECTON, DICKINSON, AND COMPANY
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 KEY STRATEGIES
• 11.7 BOSTON SCIENTIFIC CORPORATION
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 KEY STRATEGIES
• 11.8 STRYKER
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 KEY STRATEGIES
• 11.9 SMITH AND NEPHEW
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 MEDLINE INDUSTRIES, INC.
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES
• 11.11 ABBOTT
  • 11.11.1 COMPANY OVERVIEW
  • 11.11.2 FINANCIAL OVERVIEW
  • 11.11.3 PRODUCTS OFFERED
  • 11.11.4 KEY DEVELOPMENTS
  • 11.11.5 SWOT ANALYSIS
  • 11.11.6 KEY STRATEGIES
• 11.12 PETERS SURGICAL
  • 11.12.1 COMPANY OVERVIEW
  • 11.12.2 FINANCIAL OVERVIEW
  • 11.12.3 PRODUCTS OFFERED
  • 11.12.4 KEY DEVELOPMENTS
  • 11.12.5 KEY STRATEGIES
• 11.13 COLOPLAST CORP.
  • 11.13.1 COMPANY OVERVIEW
  • 11.13.2 FINANCIAL OVERVIEW
  • 11.13.3 PRODUCTS OFFERED
  • 11.13.4 KEY DEVELOPMENTS
  • 11.13.5 KEY STRATEGIES
• 11.14 TERUMO MEDICAL CORPORATION
  • 11.14.1 COMPANY OVERVIEW
  • 11.14.2 FINANCIAL OVERVIEW
  • 11.14.3 PRODUCTS OFFERED
  • 11.14.4 KEY DEVELOPMENTS
  • 11.14.5 KEY STRATEGIES
• 11.15 OLYMPUS CORPORATION
  • 11.15.1 COMPANY OVERVIEW
  • 11.15.2 FINANCIAL OVERVIEW
  • 11.15.3 PRODUCTS/SERVICES OFFERED
  • 11.15.4 KEY DEVELOPMENTS
  • 11.15.5 KEY STRATEGIES

12 APPENDIX

• 12.1 REFERENCES
• 12.2 RELATED REPORTS